AFP and diabetes mellitus: For instance, HCV-4 subtyping has been proposed to affect the response to PEG-INF alfa-2a plus RBV combination therapy.49–50 Other predictors under investigation include increased baseline insulin resistance and AFP levels.51, 52 We have shown that diabetes mellitus and AFP levels were less in sustained responders by univariate analysis.